Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform
Posted:
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund.
The MHRA published the findings of the National Commission into the Regulation of AI in Healthcare's Call for Evidence, the most substantial assessment yet of how the UK should regulate AI in health and care. The Commission is the independent advisory group…
Hospices across England are being offered access to a new NHS-backed AI programme designed to give doctors and nurses more time with patients during the final stages of life.
The initiative will provide selected hospices with free access to CLEARnotes,…
Attendees
Sponsors and Exhibitors
Contact us